Rhythm Pharmaceuticals earnings were -$264.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest RYTM earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$44.6M, down 0.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RYTM reported annual earnings of -$264.6M, with 43.3% growth. The next RYTM earnings date is May 5, 2025.
Rhythm Pharmaceuticals Earnings Reports & History FAQ
What were Rhythm Pharmaceuticals's earnings last quarter?
On RYTM's earnings call on Invalid Date, Rhythm Pharmaceuticals (NASDAQ: RYTM) reported Q4 2024 earnings per share (EPS) of -$0.72, up 2.86% year over year. Total RYTM earnings for the quarter were -$44.63 million. In the same quarter last year, Rhythm Pharmaceuticals's earnings per share (EPS) was -$0.70.
The next RYTM earnings date is Invalid Date. Add RYTM to your watchlist to be reminded of Rhythm Pharmaceuticals's next earnings date.
Is Rhythm Pharmaceuticals profitable or losing money?
As of the last Rhythm Pharmaceuticals earnings report, Rhythm Pharmaceuticals is currently losing money. Rhythm Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$260.60 million, a 41.11% increase year over year.
What was RYTM's earnings growth in the past year?
As of Rhythm Pharmaceuticals's earnings date in Invalid Date, Rhythm Pharmaceuticals's earnings has grown year over year. RYTM earnings in the past year totalled -$264.57 million.
What are Rhythm Pharmaceuticals's earnings expectations?
The current EPS estimate for Rhythm Pharmaceuticals's earnings report in Invalid Date is -$2.16.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.